Medpace Holdings (MEDP) Net Income towards Common Stockholders (2015 - 2026)

Medpace Holdings (MEDP) has reported Net Income towards Common Stockholders for 12 consecutive years, with $121.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 34.46% year-over-year to $121.4 million; the trailing twelve-month figure through Jun 2026 stood at $491.5 million (up 17.5% YoY), and the FY2025 full-year result was $451.1 million, up 11.56% from the prior year.
• Net Income towards Common Stockholders retreated to $121.4 million in Q2 2026 per MEDP's latest filing, from $123.9 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $135.1 million in Q4 2025 and bottomed at $49.4 million in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged $90.5 million across 5 years, with a median of $89.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders soared 49.45% in 2024, then gained 2.16% in 2025.
• Over 5 years, Net Income towards Common Stockholders stood at $68.7 million in 2022, then increased by 14.02% to $78.3 million in 2023, then jumped by 49.45% to $117.0 million in 2024, then gained by 15.48% to $135.1 million in 2025, then decreased by 10.19% to $121.4 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $121.4 million, $123.9 million, and $135.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.